STOCK TITAN

Ventas Stock Price, News & Analysis

VTR NYSE

Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.

Ventas, Inc. (VTR) is a leading healthcare real estate investment trust (REIT) specializing in senior housing communities, medical offices, and life science facilities. This page serves as the definitive source for official company announcements and market-moving developments.

Investors and industry professionals will find timely updates including quarterly earnings reports, property portfolio expansions, and strategic partnerships. Our curated news collection provides essential insights into operational milestones across Ventas' diversified healthcare assets.

Key coverage areas include senior housing market trends, medical office lease agreements, and research facility developments. All content is verified through primary sources to ensure accuracy and compliance with financial disclosure standards.

Bookmark this page for streamlined access to Ventas' latest press releases and sector analysis. Regularly updated to reflect new developments impacting this healthcare REIT's market position.

Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) will present at the Nareit REITweek 2022 Investor Conference on June 8, 2022 at 2:00 p.m. ET. The presentation will be available via webcast on the company’s website.

Accompanying materials, including forward-looking information, will be posted on June 7, 2022. Ventas operates a diverse portfolio of over 1,200 healthcare and real estate properties across the U.S., Canada, and the U.K., targeting senior living and medical facilities, reflecting its strong market position and sustainable growth strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.24%
Tags
conferences
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per common share. This dividend will be payable on July 14, 2022, to stockholders of record as of the close of business on July 1, 2022. Ventas operates in the healthcare and real estate sectors, owning over 1,200 properties across the US, Canada, and the UK, driven by demographic demand from an aging population. The company focuses on senior living, life sciences, and healthcare real estate, supported by a long-term growth strategy and strong financial performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.91%
Tags
dividends earnings
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has been recognized as one of the 100 best corporate citizens for the third consecutive year by 3BL Media, ranking #53 overall, improving from #67 last year. The company ranked #3 in real estate and #1 among healthcare REITs. This recognition highlights Ventas's commitment to environmental, social, and governance (ESG) practices, with the 2022 ranking considering 155 ESG factors. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on senior living, life sciences, and healthcare real estate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
none
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has received a stable outlook from S&P Global Ratings after affirming its BBB+ credit rating. The revision acknowledges Ventas’s performance recovery in senior housing, predicting continued improvement in credit metrics. The company reported a same-store SHOP occupancy of 83%, a 420 basis point increase since early 2021. Ventas's balance sheet has been strengthened by fixed-rate debt and a robust liquidity position of $2.2 billion available. Positive demographic trends are expected to bolster future occupancy recovery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
none
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced participation in investor meetings at the BMO 2022 Real Estate Summit on May 12, 2022. Management will present and share written materials that may include forward-looking information, available on the Company’s website on the same date. Ventas operates over 1,200 properties across the U.S., Canada, and the UK, focusing on healthcare and real estate driven by the aging population. As an S&P 500 company, it follows a successful long-term strategy emphasizing property diversification, financial strength, and ESG commitments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none
Rhea-AI Summary

Ventas reported Q1 2022 net income of $0.10 per share and normalized FFO of $0.79 per share, benefiting from $33 million in HHS Grants. The company's same-store cash NOI grew 5.8%, with the SHOP segment achieving 14.2% growth driven by nearly 10% revenue growth. Year-to-date, Ventas closed or committed to approximately $500 million in new investments. For Q2 2022, guidance suggests net income per share between ($0.03) and $0.01, and normalized FFO of $0.69 to $0.73. The company expects further improvement in the SHOP segment amidst inflationary pressures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has revised its management agreement with Sunrise Senior Living to enhance performance across 92 senior housing communities. The agreement aligns incentives towards Net Operating Income (NOI) growth, particularly as the senior housing industry recovers. Key terms include a new management fee structure focused on NOI, incentive payments for achieving growth targets, and enhanced operational flexibility. While the near-term financial impact is expected to be immaterial, the partnership aims to position Ventas for long-term profitability and success in the evolving market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announces the appointment of Bill Grant as Senior Vice President of Investor Relations, effective May 9, 2022. Grant, who has over 20 years of investment management experience, previously served at Morgan Stanley, overseeing $9 billion in client assets and specializing in healthcare real estate investments. His role at Ventas will focus on enhancing investor communication and articulating the company's strategic direction and growth potential, reflecting Ventas's commitment to transparency and shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
management
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced the withdrawal of proxy fight candidate Jonathan Litt from its 2022 Annual Meeting scheduled for April 27, 2022. This follows Land & Buildings' earlier withdrawal of another nominee, Michelle Applebaum. Ventas expressed appreciation for shareholder engagement and highlighted its strong asset portfolio catering to the aging population. The company encourages shareholders to vote 'FOR ALL' nominees on the WHITE proxy card, aiming for continued growth in the senior housing sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
none

FAQ

What is the current stock price of Ventas (VTR)?

The current stock price of Ventas (VTR) is $73.79 as of October 31, 2025.

What is the market cap of Ventas (VTR)?

The market cap of Ventas (VTR) is approximately 34.9B.
Ventas

NYSE:VTR

VTR Rankings

VTR Stock Data

34.91B
467.13M
0.57%
101.82%
3.41%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
CHICAGO